This metabolite contains a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 somewhere around fifty% from the guardian drug. Plasma concentrations of the metabolite are somewhere around 40% of These seen for sildenafil, so the metabolite accounts for approximately twenty% of sildenafil's pharmacologic results.And even t